Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Biotech Antitrust

WILMINGTON, Del. - Human Genome Sciences claims Genentech colluded with (nonparty) Celltech R&D to monopolize the market for producing monoclonal antibody therapeutics using recombinant DNA.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...